CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-01 | Coulie Bernard President and CEO | Sale | −105 | $35.55 | $4K | 240,112 |
| 2023-02-01 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 357,262 | ||
| 2023-01-31 | Coulie Bernard President and CEO | Exercise or conversion | +10,539 | $2.08 | $22K | 250,651 |
| 2023-01-31 | Coulie Bernard President and CEO | Exercise or conversion | +4,461 | $6.22 | $28K | 255,112 |
| 2023-01-31 | Coulie Bernard President and CEO | Sale | −15,000 | $34.92 | $524K | 240,112 |
| 2023-01-31 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −10,539 | 146,841 | ||
| 2023-01-31 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −4,461 | 372,262 | ||
| 2023-01-30 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $2.08 | $31K | 255,112 |
| 2023-01-30 | Coulie Bernard President and CEO | Sale | −11,395 | $33.98 | $387K | 243,717 |
| 2023-01-30 | Coulie Bernard President and CEO | Sale | −3,605 | $34.66 | $125K | 240,112 |
| 2023-01-30 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 157,380 | ||
| 2023-01-27 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $2.08 | $31K | 255,112 |
| 2023-01-27 | Coulie Bernard President and CEO | Sale | −8,698 | $35.42 | $308K | 246,414 |
| 2023-01-27 | Coulie Bernard President and CEO | Sale | −6,302 | $36.06 | $227K | 240,112 |
| 2023-01-27 | Coulie Bernard President and CEO | Sale | −9,779 | $35.09 | $343K | 409,538 |
| 2023-01-27 | Coulie Bernard President and CEO | Sale | −221 | $36.64 | $8K | 409,317 |
| 2023-01-26 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $2.08 | $31K | 255,112 |
| 2023-01-26 | Coulie Bernard President and CEO | Sale | −15,000 | $35.29 | $529K | 240,112 |
| 2023-01-26 | Coulie Bernard President and CEO | Sale | −15,000 | $35.10 | $526K | 419,317 |
| 2023-01-26 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 187,380 |
Page 10 of 19 · 379 trades